I
InflaRx
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Org chart
Niels C. Riedemann
CEO & Founder
Collapse
Renfeng Guo
Chief Scientific Officer & Founder
Thomas Taapken
Chief Financial Officer
Nicole Bertsch
Senior Director, Head of Human Resources
Jacky Schmitt
Senior Director Manufacturing, ext.
Daniel Vetter
Senior Director, Head of IT
Timothy E. Hermes
VP, Commercial
Michelle Medovich
Head Of Marketing
Anja Pfaff
Director, Head Of Programme Management
Board & advisors
Nicolas Fulpius
Chairman
Mark Kubler
Board Member
Richard Brudnick
Board Member
Tony Gibney
Board Member
Hege Hellstrom
Non Executive Board Member